- Identifying the medical device technologies and applications with the greatest commercial potential in the emerging markets over the near to mid-term (2008 to 2014).
- Analyzing the factors that will shape the emerging country market for advanced medical devices over the next 5 years.
- Estimating the current and future demand for specific types of medical device, by country.
- Identifying companies that are well-positioned to meet this demand, with an emphasis on companies that manufacture advanced medical equipment in the emerging markets.
Tuesday, March 30, 2010
Emerging Markets for Advanced Medical Technologies
The overall goal of this study is to provide the reader with an understanding of the demographic, economic, policy, and regulatory forces that will influence the future size and structure of the market for advanced medical devices in the largest emerging markets. Specific objectives include:
Friday, March 26, 2010
New market research reports published this week
Photocatalysts: Technologies and Global Markets (AVM069A)
Photocatalysts are materials that utilize photons to activate chemical reactions. During the last 15 years, there has been a growing interest in photocatalysts for applications in various sectors, particularly in construction and consumer products.
The main goal of this report is to provide insights into photocatalytic technology, outlining technological trends, and supplying a market analysis of various photocatalyst-based products.
To know more and to download the introduction chapter, please visit http://www.bccresearch.com/report/AVM069A.html
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics (BIO059B)
The study scope includes the major epigenomics technologies that are now, or likely to become, commercialized within the next 5 years. We examine the products flowing from these technologies, market segments into which these products are sold, and we forecast product sales for the period 2009 through 2014. We describe factors that are driving growth in these markets. Competitive dynamics and key trends in each of the market segments are discussed.
We examine the strategies of successful companies, strategic alliances, and the impact that large-scale epigenomic projects have on the industry. We profile the major companies in the industry.
The scope of our analysis includes DNA methylation and histone acetylation and methylation technologies; and the important market segments within research tools, diagnostics, therapies, and cellular therapeutics. We are particularly interested in cancer indications, which comprise the bulk of the diagnostics and therapies markets.
To know more and to download the introduction chapter, please visit http://www.bccresearch.com/report/BIO059B.html
Photocatalysts are materials that utilize photons to activate chemical reactions. During the last 15 years, there has been a growing interest in photocatalysts for applications in various sectors, particularly in construction and consumer products.
The main goal of this report is to provide insights into photocatalytic technology, outlining technological trends, and supplying a market analysis of various photocatalyst-based products.
To know more and to download the introduction chapter, please visit http://www.bccresearch.com/report/AVM069A.html
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics (BIO059B)
The study scope includes the major epigenomics technologies that are now, or likely to become, commercialized within the next 5 years. We examine the products flowing from these technologies, market segments into which these products are sold, and we forecast product sales for the period 2009 through 2014. We describe factors that are driving growth in these markets. Competitive dynamics and key trends in each of the market segments are discussed.
We examine the strategies of successful companies, strategic alliances, and the impact that large-scale epigenomic projects have on the industry. We profile the major companies in the industry.
The scope of our analysis includes DNA methylation and histone acetylation and methylation technologies; and the important market segments within research tools, diagnostics, therapies, and cellular therapeutics. We are particularly interested in cancer indications, which comprise the bulk of the diagnostics and therapies markets.
To know more and to download the introduction chapter, please visit http://www.bccresearch.com/report/BIO059B.html
Thursday, March 18, 2010
New Biotechnology reports published this week
Chiral Technology: Global Markets (BIO012E)
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for chiral products and technologies used in today’s world. The key objective is to present a comprehensive analysis of the current market and its future direction in the chiral market as an important tool for diagnosis of various diseases.
This report explores present and future strategies within the chiral market, including the synthesis, separation, and analysis of the chiral products. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. An overview of chirality, the chiral products, and the technologies used in past and present are depicted in the report.
A detailed analysis of the chiral industry structure has been conducted. This includes the chiral synthesis, chiral separation/resolution, and the chiral analysis. Revenues are broken down by the region. Sales figures are estimated for the 5-year period from 2009 through 2014.
Applications for chiral products and technologies are also discussed separately in the report, with emphasis of the usage in pharmaceutical, biochemical, and agrochemical industries. The report also covers significant patents and their allotments in each category.
Therapeutic Vaccines: The Global Market (BIO052B)
BCC’s goal in conducting this study was to determine the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015. Only a handful of such therapeutics has entered clinical use as of the beginning of 2010. For each therapeutic vaccine on the market and almost all therapeutic vaccines in mid-to-late stages of development, we have examined where they stand in the drug development process, major challenges to their approval or market success, achievements and, where applicable, the projected market for each of these drugs through 2014.
We were particularly interested in up-and-coming therapeutic vaccines in phase II or III clinical trials. We identify the leading candidates for therapeutic vaccines by disease application and also vaccine technology. In some cases we discuss notable vaccines that failed in clinical testing.
Our key objective is to present a comprehensive analysis of the current therapeutic vaccines market and its future direction.
For more information and to download the introduction chapter for free, please visit http://www.bccresearch.com/report/BIO052B.html
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for chiral products and technologies used in today’s world. The key objective is to present a comprehensive analysis of the current market and its future direction in the chiral market as an important tool for diagnosis of various diseases.
This report explores present and future strategies within the chiral market, including the synthesis, separation, and analysis of the chiral products. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. An overview of chirality, the chiral products, and the technologies used in past and present are depicted in the report.
A detailed analysis of the chiral industry structure has been conducted. This includes the chiral synthesis, chiral separation/resolution, and the chiral analysis. Revenues are broken down by the region. Sales figures are estimated for the 5-year period from 2009 through 2014.
Applications for chiral products and technologies are also discussed separately in the report, with emphasis of the usage in pharmaceutical, biochemical, and agrochemical industries. The report also covers significant patents and their allotments in each category.
Therapeutic Vaccines: The Global Market (BIO052B)
BCC’s goal in conducting this study was to determine the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015. Only a handful of such therapeutics has entered clinical use as of the beginning of 2010. For each therapeutic vaccine on the market and almost all therapeutic vaccines in mid-to-late stages of development, we have examined where they stand in the drug development process, major challenges to their approval or market success, achievements and, where applicable, the projected market for each of these drugs through 2014.
We were particularly interested in up-and-coming therapeutic vaccines in phase II or III clinical trials. We identify the leading candidates for therapeutic vaccines by disease application and also vaccine technology. In some cases we discuss notable vaccines that failed in clinical testing.
Our key objective is to present a comprehensive analysis of the current therapeutic vaccines market and its future direction.
For more information and to download the introduction chapter for free, please visit http://www.bccresearch.com/report/BIO052B.html
Friday, March 12, 2010
Custom Research Projects
While BCC Research does offer access to over 1000 market research reports on http://www.bccresearch.com/, we also do a considerable number of custom research projects with our customers worldwide.
Our team of analysts are recognized experts in the technical markets they cover and they reside in countries experiencing major market changes including: US, UK, Canada, Israel, France, Portugal, Germany, India, China, Malaysia, Brazil, Spain.
For more information on our services for custom research, visit http://www.bccresearch.com/research.php
You can also call our sales team at +1-781-489-7301 or send an email to sales@bccresearch.com
Our team of analysts are recognized experts in the technical markets they cover and they reside in countries experiencing major market changes including: US, UK, Canada, Israel, France, Portugal, Germany, India, China, Malaysia, Brazil, Spain.
For more information on our services for custom research, visit http://www.bccresearch.com/research.php
You can also call our sales team at +1-781-489-7301 or send an email to sales@bccresearch.com
Monday, March 8, 2010
Global Market for Medical Lasers to Be Worth $4.8 Billion In 2014
According to a new technical market research report, MEDICAL LASERS: TECHNOLOGIES AND GLOBAL MARKETS (HLC072A) from BCC Research (www.bccresearch.com), the global market value for medical lasers was an estimated $2.3 billion in 2009, but is expected to increase to nearly $4.8 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 16.1%.
The largest segment of the market, therapeutic medical lasers, is expected to increase at a 5-year CAGR of 13.3%, from $2 billion in 2009 to more than $3.6 billion in 2014
The diagnostic segment is expected to reach a value of nearly $1.2 billion in 2014. The market in 2009 is estimated at $328 million. Thus, the 5-year CAGR is projected to be a healthy 28.9%.
Medical lasers make up a multibillion-dollar global industry. Lasers are used in a wide range of medical applications, from cosmetic procedures to diagnosis and therapy.
The global recession that started in 2008 has had a significant negative impact on the market for medical lasers. Much of the demand for medical lasers comes from elective procedures such as laser-assisted eye surgery, which many consumers are postponing as they tighten their belts in response to the recession.
The longer-term outlook for the medical laser market is much better. Indeed, demand may experience a “bump” as the recession ends and consumers who have postponed elective laser procedures during the recession decide to have them.
Meanwhile, medical laser technology is continuing to evolve. New laser sources with potential medical applications include fiber lasers, light-emitting diodes (LEDs), and organic LEDs (OLEDs). Plastic foils as surface emitters could become important as irradiation sources in photo-dynamic therapy (PDT). Also, the spread of new laser applications such as nanosurgery, OCT, and sophisticated fluorescence microscopy will stimulate the growth of the market.
The overall goal of this study is to provide the reader with an understanding of the technological, economic, and regulatory forces that will influence the future size and structure of the market for medical lasers.
The report is intended especially for vendors of medical lasers, as well as government agencies, healthcare policy analysts, and others seeking to understand the medical applications of laser technologies. Although the report focuses on specific technologies, it is largely non-technical in nature. As such, the report’s main audience is executive management, marketing, and financial analysts.
The largest segment of the market, therapeutic medical lasers, is expected to increase at a 5-year CAGR of 13.3%, from $2 billion in 2009 to more than $3.6 billion in 2014
The diagnostic segment is expected to reach a value of nearly $1.2 billion in 2014. The market in 2009 is estimated at $328 million. Thus, the 5-year CAGR is projected to be a healthy 28.9%.
Medical lasers make up a multibillion-dollar global industry. Lasers are used in a wide range of medical applications, from cosmetic procedures to diagnosis and therapy.
The global recession that started in 2008 has had a significant negative impact on the market for medical lasers. Much of the demand for medical lasers comes from elective procedures such as laser-assisted eye surgery, which many consumers are postponing as they tighten their belts in response to the recession.
The longer-term outlook for the medical laser market is much better. Indeed, demand may experience a “bump” as the recession ends and consumers who have postponed elective laser procedures during the recession decide to have them.
Meanwhile, medical laser technology is continuing to evolve. New laser sources with potential medical applications include fiber lasers, light-emitting diodes (LEDs), and organic LEDs (OLEDs). Plastic foils as surface emitters could become important as irradiation sources in photo-dynamic therapy (PDT). Also, the spread of new laser applications such as nanosurgery, OCT, and sophisticated fluorescence microscopy will stimulate the growth of the market.
The overall goal of this study is to provide the reader with an understanding of the technological, economic, and regulatory forces that will influence the future size and structure of the market for medical lasers.
The report is intended especially for vendors of medical lasers, as well as government agencies, healthcare policy analysts, and others seeking to understand the medical applications of laser technologies. Although the report focuses on specific technologies, it is largely non-technical in nature. As such, the report’s main audience is executive management, marketing, and financial analysts.
Subscribe to:
Posts (Atom)
Posts
